Lenacapavir

Yeytuo 300 mg filmomhulde tabletten

Filmomhulde tabletNetherlandsAuthorisedAuthorised 25 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

YeytuoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lenacapavir

Yeytuo 300 mg filmomhulde tabletten

Filmomhulde tabletNetherlandsAuthorisedAuthorised 25 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

YeytuoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sunlenca 300 MG Comprimidos Recubiertos con PeliculaSpain · 306,8 mg · comprimido recubierto con película · Gilead Sciences Ireland Unlimited Company

SunlencaItaly · Compressa rivestita con film · Gilead Sciences Ireland Uc

Sunlenca film-coated tablet 300mgSingapore · 300mg · tablet, film coated · Gilead Sciences Singapore Pte. LTD.

SunlencaUnited States · 300MG BASE · tablet · Gilead Sciences INC

YeztugoUnited States · 300MG BASE · tablet · Gilead Sciences INC

SunlencaBrazil · Gilead Sciences Farmaceutica do Brasil Ltda

Sunlenca 464 MG Solucion InyectableSpain · 315,4 mg/ml · solución inyectable · Gilead Sciences Ireland Unlimited Company

SunlencaEuropean Union · Gilead Sciences Ireland Unlimited Company

SunlencaCroatia

Sunlenca solution for injection 463.5mg/1.5mlSingapore · 463.5mg/1.5ml · injection, solution · Gilead Sciences Singapore Pte. LTD.

SunlencaUnited States · 463.5MG BASE/1.5ML · solution · Gilead Sciences INC

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lenacapavir
Dosage form: Filmomhulde tablet
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 25 Aug 2025
Registration: EU/1/25/1976
Marketing authorisation holder: Gilead Sciences Ireland UC
ATC code: J05AX31
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006658
EU number: EU/1/25/1976

Yeytuo 464 mg oplossing voor injectieLenacapavir · Oplossing voor injectieNetherlands